Cargando…

Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study

BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikkelsen, Martin M, Hansen, Troels K, Gjedsted, Jakob, Andersen, Niels H, Christensen, Thomas D, Hjortdal, Vibeke E, Johnsen, Søren P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009968/
https://www.ncbi.nlm.nih.gov/pubmed/21156037
http://dx.doi.org/10.1186/1749-8090-5-129
_version_ 1782194751566512128
author Mikkelsen, Martin M
Hansen, Troels K
Gjedsted, Jakob
Andersen, Niels H
Christensen, Thomas D
Hjortdal, Vibeke E
Johnsen, Søren P
author_facet Mikkelsen, Martin M
Hansen, Troels K
Gjedsted, Jakob
Andersen, Niels H
Christensen, Thomas D
Hjortdal, Vibeke E
Johnsen, Søren P
author_sort Mikkelsen, Martin M
collection PubMed
description BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic patients undergoing elective cardiac surgery. METHODS: In a prospective study, we assessed insulin resistance and adiponectin levels from preoperative fasting blood samples in 836 patients undergoing cardiac surgery. Population-based medical registries were used for postoperative follow-up. Outcomes included all-cause death, myocardial infarction or percutaneous coronary intervention, stroke, re-exploration, renal failure, and infections. The ability of insulin resistance and adiponectin to predict clinical adverse outcomes was examined using receiver operating characteristics. RESULTS: Neither insulin resistance nor adiponectin were statistically significantly associated with 30-day mortality, but adiponectin was associated with an increased 31-365-day mortality (adjusted odds ratio 2.9 [95% confidence interval 1.3-6.4]) comparing the upper quartile with the three lower quartiles. Insulin resistance was a poor predictor of adverse outcomes. In contrast, the predictive accuracy of adiponectin (area under curve 0.75 [95% confidence interval 0.65-0.85]) was similar to that of the EuroSCORE (area under curve 0.75 [95% confidence interval 0.67-0.83]) and a model including adiponectin and the EuroSCORE had an area under curve of 0.78 [95% confidence interval 0.68-0.88] concerning 31-365-day mortality. CONCLUSIONS: Elevated adiponectin levels, but not insulin resistance, were associated with increased mortality and appear to be a strong predictor of long-term mortality. Additional studies are warranted to further clarify the possible clinical role of adiponectin assessment in cardiac surgery. TRIAL REGISTRATION: The Danish Data Protection Agency; reference no. 2007-41-1514.
format Text
id pubmed-3009968
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30099682011-01-10 Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study Mikkelsen, Martin M Hansen, Troels K Gjedsted, Jakob Andersen, Niels H Christensen, Thomas D Hjortdal, Vibeke E Johnsen, Søren P J Cardiothorac Surg Research Article BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic patients undergoing elective cardiac surgery. METHODS: In a prospective study, we assessed insulin resistance and adiponectin levels from preoperative fasting blood samples in 836 patients undergoing cardiac surgery. Population-based medical registries were used for postoperative follow-up. Outcomes included all-cause death, myocardial infarction or percutaneous coronary intervention, stroke, re-exploration, renal failure, and infections. The ability of insulin resistance and adiponectin to predict clinical adverse outcomes was examined using receiver operating characteristics. RESULTS: Neither insulin resistance nor adiponectin were statistically significantly associated with 30-day mortality, but adiponectin was associated with an increased 31-365-day mortality (adjusted odds ratio 2.9 [95% confidence interval 1.3-6.4]) comparing the upper quartile with the three lower quartiles. Insulin resistance was a poor predictor of adverse outcomes. In contrast, the predictive accuracy of adiponectin (area under curve 0.75 [95% confidence interval 0.65-0.85]) was similar to that of the EuroSCORE (area under curve 0.75 [95% confidence interval 0.67-0.83]) and a model including adiponectin and the EuroSCORE had an area under curve of 0.78 [95% confidence interval 0.68-0.88] concerning 31-365-day mortality. CONCLUSIONS: Elevated adiponectin levels, but not insulin resistance, were associated with increased mortality and appear to be a strong predictor of long-term mortality. Additional studies are warranted to further clarify the possible clinical role of adiponectin assessment in cardiac surgery. TRIAL REGISTRATION: The Danish Data Protection Agency; reference no. 2007-41-1514. BioMed Central 2010-12-14 /pmc/articles/PMC3009968/ /pubmed/21156037 http://dx.doi.org/10.1186/1749-8090-5-129 Text en Copyright ©2010 Mikkelsen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mikkelsen, Martin M
Hansen, Troels K
Gjedsted, Jakob
Andersen, Niels H
Christensen, Thomas D
Hjortdal, Vibeke E
Johnsen, Søren P
Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title_full Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title_fullStr Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title_full_unstemmed Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title_short Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
title_sort insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009968/
https://www.ncbi.nlm.nih.gov/pubmed/21156037
http://dx.doi.org/10.1186/1749-8090-5-129
work_keys_str_mv AT mikkelsenmartinm insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT hansentroelsk insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT gjedstedjakob insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT andersennielsh insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT christensenthomasd insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT hjortdalvibekee insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy
AT johnsensørenp insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy